Early growth response factor-1 in acute lung injury
Early growth response factor-1 in acute lung injury
复制标题
DOI:
10.1152/ajplung.00265.2007
复制
发表时间:
2007-11-01
影响因子:
4.9
通讯作者:
Kavanagh, Brian P.
中科院分区:
文献类型:
--
作者:
Ngiam, Nicola;Post, Martin;Kavanagh, Brian P.
EARLY GROWTH RESPONSE FACTOR-1 (EGR1), a nuclear transcription factor, was discovered 15 years ago and belongs to a larger family of early response genes. It appears to function as a convergence point for many signaling pathways, including those involved in inflammation and apoptosis, and its expression is rapidly induced by a variety of stimuli. The induced EGR1 protein is thought to couple external stimuli to intracellular events by altering the expression of EGR1 target genes such as tissue factor, vascular endothelial growth factor (VEGF), intercellular adhesion molecule 1 (ICAM1), proteins that are common in organ injury. Because EGR1 appears to mediate responses to sepsis (22) and reperfusion injury (28), as well as intensify inflammatory responses (28), it may be important in the pathogenesis of critical illness. This perspective aims to summarize the current state of knowledge of the effects and mechanisms of EGR1 in acute illness states. EGR1 and acute lung injury. EGR1 is induced by a variety of stimuli in the lung, including hypoxia (29), hyperoxia, ischemia-reperfusion (28), and high tidal volume (4). Exposure to low oxygen concentrations (6–20%) resulted in EGR1 mRNA induction that was greater with lower O2 concentrations and longer exposure times (29). Upregulation of EGR1 DNA binding secondary to hypoxia was also shown to activate tissue factor in mononuclear macrophages, and its absence (ie, in EGR1 null mice) was associated with reduced tissue factor activation and fibrin deposition in the lungs following exposure to hypoxia (30). Supporting these findings is a recent study in which EGR1 protein upregulation greatly augmented the induction of serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 (SERPINE1) in mouse macrophages following exposure to hypoxia (17). This may be especially important as SERPINE1 plays a key role in suppressing fibrinolysis, and its upregulation could therefore be a necessary element in the development of hypoxia-induced thrombosis (17). Ischemia-reperfusion reflects processes that are central to many acute illness states. In murine pulmonary ischemiareperfusion, EGR1 mRNA upregulation was evident and localized to lung macrophages and smooth muscle cells (28). Moreover, EGR1 knockout mice had longer survival and lower levels of circulating inflammatory mediators, as well as reduced fibrin and leukocyte accumulation compared with wild-type mice, following exposure to pulmonary ischemiareperfusion (28). The same inflammatory mediators examined in the ischemia-reperfusion model stated above were strongly activated by LPS (ie, endotoxin) administration, a model of sepsis, in the knockout mice. This study implicates EGR1 activation in the pathogenesis of ischemic lung tissue damage and delineates specific downstream inflammatory mediators involved, including ICAM1, IL-1, coagulation factor III (thromboplastin, tissue factor)(F3), SERPINE1, and VEGF (28).We have previously found, using gene array techniques, that high tidal volume ventilation in rats increased the expression of several genes, including EGR1 (4). This upregulation was evident 30 min after the initiation of injurious ventilation and well before lung injury was demonstrable by histological assessment (4). These findings were further substantiated in fetal lung epithelial cells subjected to in vitro stretch (5).